BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5057001)

  • 1. Clofibrate and nicotinic acid.
    Hoffer A
    Can Med Assoc J; 1972 Sep; 107(6):488 passim. PubMed ID: 5057001
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Lipid-lowering drugs after myocardial infarction.
    Lancet; 1975 Mar; 1(7905):501-2. PubMed ID: 46964
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drugs which decrease serum lipids].
    Oye I
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):32-3. PubMed ID: 4691222
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological treatment of hyperlipoproteinemias--theory and practice].
    Frisk-Holmberg M
    Lakartidningen; 1974 Aug; 71(34):3083-6. PubMed ID: 4410383
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arteriosclerosis--nicotinic acid therapy. 8. Treatment of hyperlipemia].
    Sigroth K
    Lakartidningen; 1971 Apr; 68(15):1765-7. PubMed ID: 5577250
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A; Buzzelli G; D'Alessandro A
    Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arteriosclerosis--nicotinic acid therapy. 10. Combination therapy in hyperlipemia].
    Hansen PF
    Lakartidningen; 1971 Apr; 68(15):1769-72. PubMed ID: 5577252
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arteriosclerosis--nicotinic acid therapy. 2. Alterations in serum lipoproteins. Diagnosis, therapy].
    Gustafson A
    Lakartidningen; 1971 Apr; 68(15):1744-5 passim. PubMed ID: 5577244
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hiperlipidemia as a risk factor in coronary artery disease].
    Michajlik A
    Wiad Lek; 1973 Mar; 26(6):529-34. PubMed ID: 4572266
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of essential hypercholesterolemia with clofibrate and nicotinic acid.
    Nordoy A; Gjone E
    Acta Med Scand; 1970 Dec; 188(6):487-90. PubMed ID: 5494813
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
    Wilke H; Frahm H
    Dtsch Med Wochenschr; 1976 Mar; 101(11):401-5. PubMed ID: 1253701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofibrate and niacin in coronary heart disease.
    JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963
    [No Abstract]   [Full Text] [Related]  

  • 15. [Letter: Clofibrate and clofibrate-inositolnicotinate].
    Rahlfs VW
    Dtsch Med Wochenschr; 1976 Jun; 101(25):975. PubMed ID: 1278017
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1975; 22(1):91-101. PubMed ID: 1098680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug treatment of hyperlipidemia.
    Berkowitz D
    Mod Treat; 1969 Nov; 6(6):1341-51. PubMed ID: 5377637
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum lipid-lowering drugs following myocardial infarction].
    Schettler G
    Dtsch Med Wochenschr; 1975 Aug; 100(31):1611-2. PubMed ID: 168052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.